Neupedix (Alprostadil)

Alprostadil, the active ingredient in Neupedix, is a prostaglandin analog presented as an injection for intravenous use. It treats erectile dysfunction in adult males and maintains patent ductus arteriosus in neonates requiring circulatory support.\n\nGNH India supplies Neupedix as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Alprostadil acts on the prostaglandin pathway to produce vasodilation in targeted vascular beds.\n\nErectile dysfunction: improves penile arterial inflow to facilitate erection.\nMaintenance of patent ductus arteriosus in neonates: sustains ductal patency to ensure adequate systemic oxygenation.\nPharmacologic stress testing: induces coronary vasodilation for diagnostic imaging of myocardial perfusion.

Alprostadil may cause a range of adverse reactions, which are grouped by frequency.\n\nCommon Side Effects:\n- Penile pain or discomfort\n- Headache\n- Flushing or warmth sensation\n- Hypotension or dizziness\n- Nausea or vomiting\n- Injection site erythema\n\nSerious or Rare Side Effects:\n- Priapism lasting more than four hours\n- Severe hypotension leading to syncope\n- Anaphylactic or severe allergic reaction\n- Significant bleeding at the injection site\n- Penile fibrosis with repeated use\n- Cardiovascular events such as myocardial ischemia

Before using Neupedix, clinicians should evaluate patient‑specific risk factors and monitor for adverse events.\n\nAssess cardiovascular status: evaluate for uncontrolled hypertension or recent myocardial infarction.\nAvoid use in patients with hypersensitivity: do not administer to individuals allergic to alprostadil or other prostaglandins.\nMonitor blood pressure: watch for hypotension during and after infusion.\nUse caution in patients with bleeding disorders: increased risk of hemorrhage at injection sites.\nPregnancy and lactation: safety not established; avoid unless benefits outweigh potential risks.\nStore at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Alprostadil can interact with other agents that affect vascular tone or coagulation.\n\nMajor Interactions (Avoid):\n- Nitrates (e.g., nitroglycerin): may cause profound hypotension.\n- Alpha‑blockers (e.g., prazosin): additive blood‑pressure lowering effect.\n- Other prostaglandin analogs: risk of excessive vasodilation.\n\nModerate Interactions (Monitor Closely):\n- Phosphodiesterase‑5 inhibitors (e.g., sildenafil): monitor for synergistic vasodilatory response.\n- Antihypertensive drugs (e.g., ACE inhibitors, beta‑blockers): may require dose adjustment.\n- Diuretics: potential for enhanced orthostatic hypotension.\n- Anticoagulants/antiplatelet agents: increased bleeding risk at injection site.\n- NSAIDs: may blunt prostaglandin‑mediated effects.